Association of hematological indices with prediabetes
A cross-sectional study
Keywords:
Prediabetes, Blood Cells, Leukocytes, Erythrocytes, Diabetes MellitusAbstract
Background: Prediabetes is a condition that occurs when blood glucose levels are higher than normal, but not high enough to be classified as diabetes. Prediabetic people have an increased risk of developing type 2 diabetes and cardiovascular disease. Moreover Hyperglycemia has multiple effects on the hematological parameters.
Objective: To examine the association between hematological indices and anthropometric measurement, with prediabetes.
Methods: This cross-sectional study was conducted on 125 diabetics and 259 prediabetics in the 20-70 age range. They were selected by a convenience sampling method at the Taban Diabetes Center in 2015. An oral glucose tolerance test was performed for each participant who had never been diagnosed with diabetes. Participants were characterized as having prediabetes or diabetes according to American Diabetes Association criteria. The hematologic parameters were measured by using Sysmex-KX 21N analyzers. Data were analyzed by IBM-SPSS version 22 using independent-samples t-test, Mann-Whitney U test, and Pearson’s correlation coefficient at p<0.05.
Results: There was significant difference in mean corpuscular hemoglobin concentration (MCVH) (33.81±0.92 g/dL vs. 34.06±1.05 g/dL) between prediabetes patients and diabetes. There was not a statistically significant difference in the prediabetics’ hematological parameters, compared with the diabetics. In the prediabetic group, only the mean corpuscular hemoglobin concentration was found to be negatively correlated with diastolic blood pressure (p=0.013) and FBS (p=0.026).
Conclusion: Hematological indices are important markers for the assessment of variations in size, number, and maturity of different blood cells. Hematological indices could be utile indicators of vascular complication and glycemic control in type 2 DM patients. Thus, they are important for the evaluation and early management of patients with per diabetes.
References
Shahbazian H. World diabetes day; 2013. J Renal Inj Prev. 2013; 2(4): 123-4. doi: 10.12861/jrip.2013.39.
Elalamy I, Chakroun T, Gerotziafas GT, Petropoulou A, Robert F, Karroum A, et al. Circulating platelet
leukocyte aggregates: a marker of microvascular injury in diabetic patients. Thromb Res. 2008; 121(6):
–8. doi: 10.1016/j.thromres.2007.07.016. PMID: 17825880.
Jindal S, Gupta S, Gupta R, Kakkar A, Singh HV, Gupta K, et al. Platelet indices in diabetes mellitus:
indicators of diabetic microvascular complications. Hematology. 2011; 16(2): 86–9. doi:
1179/102453311X12902908412110.
Demirtas L, Degirmenci H, Akbas EM, Ozcicek A, Timuroglu A, Gurel A, et al. Association of
hematological indices with diabetes, impaired glucose regulation and microvascular complications of
diabetes. Int J Clin Exp Med. 2015; 8(7): 11420-5. PMID: 26379958, PMCID: PMC4565341.
Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. The natural history of progression from normal
glucose tolerance to type 2 diabetes in the Baltimore longitudinal study of aging. Diabetes. 2003; 52(6):
-84. doi: 10.2337/diabetes.52.6.1475. PMID: 12765960.
Levitzky YS, Pencina MJ, D’Agostino RB, Meigs JB, Murabito JM, Vasan RS, et al. Impact of Impaired
Fasting Glucose on Cardiovascular Disease. J Am Coll Cardiol. 2008; 51(3): 264-70. doi:
1016/j.jacc.2007.09.038.
Cho YI, Mooney MP, Cho DJ. Hemorheological disorders in diabetes mellitus. J Diabetes Sci Technol.
; 2(6): 1130-8. doi: 10.1177/193229680800200622. PMID: 19885302, PMCID: PMC2769810.
Tamariz LJ, Young JH, Pankow JS, Yeh HC, Schmidt MI, Astor B, et al. Blood viscosity and hematocrit as
risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J
Epidemiol. 2008; 168: 1153-60. doi: 10.1093/aje/kwn243. PMID: 18931370, PMCID: PMC2581671.
Biadgo B, Melku M, Abebe SM, Abebe M. Hematological indices and their correlation with fasting blood
glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest
Ethiopia. Diabetes Metab Syndr Obes. 2016; 9: 91-9. doi: 10.2147/DMSO.S97563. PMID: 27042134,
PMCID: PMC4801204.
Chen LK, Ming-Hsien L, Zhi-Jun C, Shinn-Jang H, Chiou ST. Association of insulin resistance and
hematologic parameters: study of a middle-aged and elderly Chinese population in Taiwan. J Chin Med
Assoc. 2006; 69(6): 248–53. doi: 10.1016/S1726-4901(09)70251-5. PMID: 16863009.
Simmons D. Increased red cell count in diabetes and pre-diabetes. Diabetes Res Clin Pract. 2010; 90(3):
e50-3. doi: 10.1016/j.diabres.2010.07.005. PMID: 20701991.
Gokulakrishnan K, Deepa R, Sampathkumar R, Balasubramanyam M, Mohan V. Association of leukocyte
count with varying degrees of glucose intolerance in Asian Indians: the Chennai Urban Rural
Epidemiology Study (CURES-26). Metab Syndr Relat Disord. 2009; 7(3): 205-10. doi:
1089/met.2008.0024. PMID: 19284318.
Coban E, Kucuktag S, Basyigit S. Platelet activation in subjects with impaired glucose tolerance. Platelets.
; 18: 591-4. doi: 10.1080/09537100701609019. PMID: 18041650.
Anuurad E, Shiwaku K, Nogi A, Kitajima K, Enkhmaa B, Shimono K, et al. The new BMI criteria for
asians by the regional office for the western pacific region of WHO are suitable for screening of overweight
to prevent metabolic syndrome in elder Japanese workers. J Occup Health. 2003; 45(6): 335-43. doi:
1539/joh.45.335. PMID: 14676412.
American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010;
(Suppl 1): S62–9. doi: 10.2337/dc10-S062. PMID: 20042775, PMCID: PMC2797383.
Tan BT, Nava AJ, George TI. Evaluation of the Beckman Coulter UniCel DxH 800, Beckman Coulter LH
, and Abbott Diagnostics Cell-Dyn Sapphire hematology analyzers on adult specimens in a tertiary care
hospital. Am J Clin Pathol. 2011; 135: 939-51. doi: 10.1309/AJCP1V3UXEIQTSLE. PMID: 21571967.
Ezenwaka CE, Jones-Lecointe A, Nwagbara E, Seales D, Okali F. Anemia and kidney dysfunction in
Caribbean type 2 diabetic patients. Cardiovasc Diabetol. 2008; 7: 25. doi: 10.1186/1475-2840-7-25.
Meisinger C, Rückert IM, Stöckl D, Thorand B, Peters A, Kowall B, et al. Hematological Parameters and
Prediabetes and Diabetes in Adults from the General Population: A Cross-Sectional Study. J Diabetes
Metab. 2014; 5: 2. doi: 10.4172/2155-6156.1000335.
Du X, Zhu B, Hu G, Mao W, Wang S, Zhang H, et al. U-shape association between white blood cell count
and the risk of diabetes in young Chinese adults. Diabet Med. 2009; 26(10): 955-60. doi: 10.1111/j.1464- 5491.2009.02801.x. PMID: 19900225.
Moradi S, Kerman SR, Rohani F, Salari F. Association between diabetes complications and leukocyte
counts in Iranian patients. J Inflamm Res. 2012; 5: 7-11. doi: 10.2147/JIR.S26917. PMID: 22334791,
PMCID: PMC3278259.
Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, et al. White blood cell count is associated with
macro- and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care. 2004;
(1): 216-22. doi: 10.2337/diacare.27.1.216. PMID: 14693992.
Qiu M, Shen W, Song X, Ju L, Tong W, Wang H, et al. Effects of prediabetes mellitus alone or plus
hypertension on subsequent occurrence of cardiovascular disease and diabetes mellitus: longitudinal study.
Hypertension. 2015; 65(3): 525-30. doi: 10.1161/HYPERTENSIONAHA.114.04632. PMID: 25624343.
Shim WS, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, et al. The association of total and differential
white blood cell count with metabolic syndrome in type 2diabetic patients. Diabetes Res Clin Pract. 2006;
(3): 284-91. doi: 10.1016/j.diabres.2006.02.001. PMID: 16563549.
Chung FM, Tsai JC, Chang DM, Shin SJ, Lee YJ. Peripheral total and differential leukocyte count in
diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care. 2005; 28(7): 1710-7.
doi: 10.2337/diacare.28.7.1710. PMID: 15983324.
Dada OA, Uche E, Akinbami A, Odesanya M, John-Olabode S, Adediran A, et al. The relationship
between red blood cell distribution width and blood pressure in patients with type 2 diabetes mellitus in
Lagos, Nigeria. J Blood Med. 2014; 5: 185-9. doi: 10.2147/JBM.S67989.
Malandrino N, Wu WC, Taveira TH, Whitlatch HB, Smith RJ. Association between red blood cell
distribution width and macrovascular and microvascular complications in diabetes. Diabetologia. 2012;
(1): 226-35. doi: 10.1007/s00125-011-2331-1.
Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose.
Am J Physiol. 1992; 263(2 Pt 2): H321-6. PMID: 1510128.
King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell
Biol. 2004; 122(4): 333-8. doi: 10.1007/s00418-004-0678-9.
Gerner RR, Wieser V, Moschen AR, Tilg H. Metabolic inflammation: role of cytokines in the crosstalk
between adipose tissue and liver. Can J Physiol Pharmacol. 2013; 91(11): 867-72. doi: 10.1139/cjpp-2013- 0050. PMID: 24117253.
Cawood TJ, Buckley U, Murray A, Corbett M, Dillon D, Goodwin B, et al. Prevalence of anaemia in
patients with diabetes mellitus. Ir J Med Sci. 2006; 175(2): 25-7. doi: 10.1007/BF03167944. PMID:
Wang ZS, Song ZC, Bai JH, Li F, Wu T, Qi J, et al. Red blood cell count as an indicator of microvascular
complications in Chinese patients with type 2 diabetes mellitus. Vasc Health Risk Manag. 2013; 9: 237-43.
doi: 10.2147/VHRM.S43211. PMID: 23690689, PMCID: PMC3656917.
Stevens PE. Anaemia, diabetes and chronic kidney disease: where are we now? J Ren Care. 2012; 38 Suppl
: 67-77. doi: 10.1111/j.1755-6686.2012.00281.x.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
